AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$AMBA

Young John Alexander sold $203K of AMBA

Young John Alexander (CFO) sold 3,126 shares of AMBARELLA INC (AMBA) at $64.83 ($0.20M total) on 2026-09-17.

Original reporting
SEC EDGAR · Young John Alexander
Published Sep 18, 2026, 8:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 8:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$AMBA
Neutral
medium confidence
Mentioned
$AMBA
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBANeutralLow
01

Why it matters

The CFO's sale is a primary disclosure but modest in scale.

02

Market read

Minor insider sale with limited market impact.

03

What to watch

No other material news about Amba at this time.

Relevance 4/10Novelty 5/10Timing: post-market 2026-09-17

Background

SEC Form 4 filing discloses insider transaction.

Company-level read

Ticker impact

$AMBANeutralMedium confidence
Context

CFO Young John Alexander sold 3,126 shares for $202,658, reducing his stake to 109,702 shares.

Expected impact

Potential slight downward pressure in near term.

Evidence & confidence

Sale amount is under $1M and represents a small percentage of holdings; market reaction likely limited.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Insider sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Company
    AmbaRELLA Inc.

    US-listed medical device company.

  • Executive
    Young John Alexander

    Chief Financial Officer of AmbaRELLA.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

AMBA insider trading history →

Related articles

$AMBAMed

Ambarella (AMBA) Shares Rise 2.4% Amid Nvidia Acquisition Specul

Ambarella (AMBA) shares rose 2.4% on reports Nvidia (NVDA) may join acquisition talks, alongside NXP (NXPI) and Qualcomm (QCOM). The company's P/S ratio is 6.7x, below historical and industry medians, reflecting market skepticism. Insider activity shows $17.1M in sales over the past year. Ambarella specializes in low-power semiconductor solutions for video and AI applications.

gurufocus.com
$AMBAHighAI 8/10

Ambarella speculated to have a rival suitor - Betaville

Ambarella (AMBA) may have a second potential buyer, following reports of NXP Semiconductors (NXPI) exploring an acquisition. Traders suggest a bid of 75% cash and 25% shares, valued between $95 and $105 per share, citing a Betaville alert. The identity of the new suitor is unknown.

tradingview.com
$AMBAHighAI 9/10

ZEDEDA Deal Targets $30B Edge AI Market

Ambarella and ZEDEDA announced a partnership on September 15, 2026, integrating ZEDEDA's EVE-OS with Ambarella's N1 edge AI chips. The deal targets the $30B edge AI market, with developer kits expected in Q4 2026. Ambarella reported Q2 2026 revenue of $108.1M, up 13.2% YoY, while ZEDEDA has raised over $129M in funding.

shattered.io